Back to Agenda
Session 1: Keynote Address: Update from the Office of Combination Products
Session Chair(s)
James Wabby, MHS
Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States
Session 1: Keynote Address: Update from the Office of Combination Products
Speaker(s)
Speaker
Thinh X. Nguyen
FDA, United States
Director, Office of Combination Products, OCPP
Have an account?